Retatrutide Oral

Retatrutide Oral is the oral form of the triple agonist Retatrutide — the same molecule, in a route of administration that needs no injection, no pen and no reconstitution. Retatrutide acts on the GLP-1, GIP and glucagon receptors at once. That multi-receptor activity is why the molecule is treated as the next step in metabolic control rather than yet another GLP-1 analogue. The oral form targets those for whom an injectable protocol is the obstacle — whether because of needles, or because of the refrigeration and preparation each dose requires. Dosing is daily and needs no consumables. No solvent, no syringes, no reconstitution. Research material. Not a medicinal product and not a substitute for medical advice.